Targeting telomere maintenance mechanisms in SCLC

The majority of SCLCs exhibit very high telomerase levels, which are generally associated with the process of malignant transformation. Whether this is also true for SCLC and whether telomerase inhibitors have anti-tumor efficacy in in vivo and in vitro SCLC models also in combination with other targeted drugs will be analyzed in A03 by M. Fischer.

Principal Investigator

Univ. Prof. Dr. med. Matthias Fischer SFB1399
Univ. Prof. Dr. med. Matthias Fischer

Professor (W2) and Head of the Department of Experimental Pediatric Oncology

University Hospital of Cologne

Department of Experimental Pediatric Oncology

Center for Molecular Medicine Cologne (CMMC)

Curriculum Vitae (CV)